Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJérémie Bouteau, Thibaud Genet
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Efficacy of spironolactone in patients with heart failure with preserved ejection fraction following acute myocardial infarction: a multicenter retrospective cohort analysis
10.1016/j.amjmed.2026.03.049 · 2026
Uses and limitations of the restricted mean survival time: illustrative examples from cardiovascular outcomes and mortality trials in Type 2 Diabetes
10.7326/m19-3286 · 2020
Nonproportional hazards for time-to-event outcomes in clinical trials: JACC review topic of the week
10.1016/j.jacc.2019.08.1034 · 2019
Spironolactone for heart failure with preserved ejection fraction
10.1056/nejmoa1313731 · 2014
Routine spironolactone in acute myocardial infarction
10.1056/nejmoa2405923 · 2025
No additional external references are available.